Valerie G. Press to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Valerie G. Press has written about Diabetes Mellitus, Type 2.
Connection Strength
0.670
-
Variations in the Design and Use of Attention Control Groups in Type 2 Diabetes Randomized Controlled Trials: a Systematic Review. Curr Diab Rep. 2023 09; 23(9):217-229.
Score: 0.463
-
Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis. J Gen Intern Med. 2022 02; 37(2):439-448.
Score: 0.104
-
The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis. J Gen Intern Med. 2022 02; 37(2):415-438.
Score: 0.103